Saturday 17 October 2026
Export PACS’s income statement to Excel — free account
PACS Group, Inc.
PACS Healthcare Medical Care Facilities
PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 9.07%, EPS grew 45.5%, free cash flow grew 220.5% and total debt fell 4.30%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.
46.91
0.84
−1.76%
Follow PACS
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 4 | 7 |
P/E ratio |
26.89 | 26.89 | 26.89 | 32.20 | 31.47 |
Altman Z-Score |
— | — | — | 1.13 | 2.00 |
P/S ratio |
0.89 | 0.89 | 0.89 | 0.47 | 1.13 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 6.36 | 20.01 |
Altman Z″-Score (non-manufacturers) |
— | 0.81 | 1.01 | 0.35 | 0.85 |
Beneish M-Score |
— | — | (1.95) | (2.39) | (2.74) |
P/Operating CF |
50.39 | 50.39 | 50.39 | 29.77 | (1,768.67) |
P/B ratio |
22.16 | 22.16 | 22.16 | 2.69 | 6.30 |
Price to Tangible BV |
43.35 | 43.35 | 43.35 | 2.96 | 6.78 |
EV/Sales |
1.10 | 1.10 | 1.10 | 0.50 | 1.16 |
EV/EBITDA |
14.78 | 14.78 | 14.78 | 12.16 | 16.69 |
EV/Operating CF |
84.90 | 84.90 | 84.90 | 5.53 | 15.21 |
EV/FCF |
(546.96) | (546.96) | (546.96) | 6.72 | 20.52 |
Quick Ratio |
— | 0.99 | 1.47 | 0.89 | 0.90 |
Current Ratio |
— | 1.06 | 1.58 | 0.96 | 1.07 |
Net Debt/EBITDA |
0.00 | 1.75 | 2.75 | 0.65 | 0.41 |
Debt/Assets |
0.00% | 20.30% | 20.85% | 5.07% | 6.25% |
Debt/Equity |
0.00 | 7.28 | 7.20 | 0.37 | 0.37 |
Asset Turnover |
0.00 | 1.97 | 1.04 | 0.93 | 0.98 |
Operating CF/Net income |
1.20 | 0.62 | 0.56 | 6.59 | 2.11 |
Capex/Depreciation |
(15.40) | (0.97) | (1.42) | (1.48) | (1.78) |
Interest Coverage |
15.79 | 8.98 | 4.16 | 2.78 | 10.92 |
| 0.00% | 0.00% | 132.50% | 13.64% | 22.96% | |
| 0.00% | 12.23% | 3.78% | 1.27% | 3.54% | |
ROIC |
0.00% | 28.10% | 17.07% | 9.34% | 17.52% |
Return on Tangible Assets |
0.00% | 32.87% | 13.39% | 5.87% | 15.09% |
Average Days of Receivables |
0.00 | 63.31 | 70.39 | 63.95 | 48.45 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
8.30% | 6.15% | 6.87% | 8.41% | 7.85% |
Intangible Assets out of Total Assets |
0.00 | 0.03 | 0.02 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 2.83% | 1.02% |
Graham Net Nets |
(0.98) | (0.98) | (0.98) | (1.87) | (0.59) |
Graham Number |
0.00 | 0.00 | 3.95 | 6.69 | 12.94 |
Earnings Yield |
3.72% | 3.72% | 3.72% | 3.11% | 3.18% |
Free Cash Flow Yield |
(0.23%) | (0.23%) | (0.23%) | 15.73% | 5.00% |
Revenue per Share |
9.06 | 18.82 | 24.17 | 27.89 | 33.86 |
Operating CF per Share |
0.45 | 0.72 | 0.49 | 2.50 | 2.59 |
Capex per Share |
(0.96) | (0.18) | (0.35) | (0.44) | (0.67) |
Free Cash Flow per Share |
(0.52) | 0.54 | 0.15 | 2.06 | 1.92 |
Cash per Share |
0.00 | 0.45 | 0.57 | 1.08 | 1.26 |
Shareholders Equity per Share |
0.00 | 0.53 | 0.79 | 4.88 | 6.10 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.53 | 0.79 | 4.88 | 6.10 |
Free Cash Flow |
(66.48) | 69.76 | 18.67 | 302.38 | 299.57 |
Working Capital |
— | 27.30 | 265.22 | (40.17) | 68.31 |
Capital Expenditures |
(124.09) | (22.85) | (45.03) | (64.96) | (104.65) |
Net Current Asset Value |
0.00 | (1,882.08) | (2,688.87) | (3,588.96) | (3,561.85) |
EV/EBIT |
17.14 | 17.14 | 17.14 | 16.50 | 19.86 |
Capex to Sales |
0.11 | 0.01 | 0.01 | 0.02 | 0.02 |
Price to Operating Income |
13.85 | 13.85 | 13.85 | 15.62 | 19.37 |
| Other line items | |||||
Depreciation/Fixed assets |
0.00 | 0.05 | 0.05 | 0.04 | 0.05 |
Cash ROIC |
0.00% | 11.13% | 2.06% | 26.54% | 19.99% |
Accounts Receivable Turnover |
0.00 | 0.00 | 6.10 | 6.21 | 7.46 |
Accounts Payable Turnover |
0.00 | 0.00 | 21.19 | 22.67 | 24.55 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 19.97 | 19.31 | 17.84 | 15.56 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 510.10 | 658.29 | 709.31 |
Average Payables |
— | — | 125.76 | 158.00 | 183.65 |
Average Assets |
— | 1,230.95 | 2,987.32 | 4,377.82 | 5,413.47 |
Average Common Equity |
— | — | 85.19 | 408.71 | 834.07 |
Columns are period end dates